About
Vetosine is developing and commercializing a first-in-class disease modifying osteoarthritis drug (DMOAD) for animals, initially focusing on dogs, to provide therapy options beyond NSAIDs, diet, and exercise by maintaining healthy joint cartilage.
Explore Vetosine's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.